Company Overview
About Elligo Health Research
Elligo Health Research is a clinical research organization (CRO) and technology company founded in 2016 and headquartered in Austin, Texas, that embeds clinical trials within existing healthcare environments rather than requiring dedicated research centers. The company's model enables practicing physicians and health systems to conduct clinical trials for their own patients by providing the infrastructure, personnel, regulatory expertise, and data integration needed to run trials — without requiring those providers to become stand-alone research sites. This "research-in-care" approach significantly broadens the pool of potential trial sites and patients.
Business Model & Competitive Advantage
Elligo's platform leverages electronic health records (EHRs) to identify patients who meet clinical trial eligibility criteria, dramatically improving the speed and accuracy of patient identification and recruitment — one of the most time-consuming and expensive phases of clinical trial execution. By connecting trial sponsors and CROs with real-world patient populations at the point of care, Elligo reduces the screening failures and slow enrollment that are major contributors to trial delays and cost overruns.
Competitive Landscape 2025–2026
The company has activated more than 850 investigator sites across US health systems, physician groups, and specialty practices, enabling access to diverse patient populations that are often underrepresented in traditional academic medical center-dominated clinical trials. Elligo partners with pharmaceutical companies, biotechs, and CROs that need to accelerate enrollment and improve trial diversity. The company has raised institutional venture funding and been recognized as one of the most innovative companies in clinical research for its approach to decentralizing trial site infrastructure.
Key Differentiators
Strong Challenger
Elligo Health Research is an established challenger with significant market presence and competitive offerings in Life Sciences & BioTech.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Tempus
Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder o
Emulate
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m
ConcertAI
ConcertAI is a Boston-based company that combines artificial intelligence with real-world oncology data to accelerate cancer drug development and improve patient outcomes. Its platform integrates mult
DNAnexus
DNAnexus is the category-defining cloud platform for precision health data management, analysis, and collaboration. Founded in 2009 and headquartered in Mountain View, California, DNAnexus provides a
Schrödinger
Schrödinger was founded in 1990 by Richard Friesner and David Pearlman in New York City, building physics-based computational methods for molecular simulation. For over 30 years the company has develo
Florence Healthcare
Florence Healthcare is the dominant software platform for clinical trial site enablement, providing digital tools that connect trial sites, sponsors, and contract research organizations (CROs) to stre
Compare Elligo Health Research with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Elligo Health Research? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Elligo Health Research Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Elligo Health Research vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →